Although these are exciting times for digital healthcare with business processes and models enabling individuals to understand and quantify more about their health and genome than ever before, privacy remains a security concern.
“If people share their medical information with a technology company, who owns the data?” asks Caroline Rivett, head of KPMG in the UK's Information Protection team in Life Sciences and Healthcare. “How can or should the company share it? What implications does this have for the individual – and for their family members?
”This much-needed debate on privacy matters is starting in areas such as genome mapping for cancer research. But, it will need to extend beyond that to other applications, in particular medical devices.
Read our full article, including recommendations on what organisation should be doing to address these and other privacy issues.
© 2018 KPMG Limited, a Gibraltar Limited Liability Company and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.